Catalyst Wire Dossier Catalyst Wire Dossier

Fluoropyrimidine (class)

fluoropyrimidine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fluoropyrimidine (class), covering 2016-11-02 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: GDC-0980 in Combination With a Fluoropyrimidine, Oxaliplatin, and Bevacizumab in Patients With Advanced Solid Tumors [Phase 1]

See pricing